MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1541 to 1560 of 166,322 approvalsPage 78 of 8317

Efsubaglutide Alfa Injection

Approval Number: 国药准字S20250009
Registration: Jan 24, 2025
上海银诺医药技术有限公司

Omeprazole and Sodium Bicarbonate for Suspension（Ⅰ）

Approval Number: 国药准字H20253244
Registration: Jan 24, 2025
山东益康药业股份有限公司

Ritonavir Tablets

Approval Number: 国药准字H20253280
Registration: Jan 24, 2025
齐鲁制药（海南）有限公司

Nimodipine Oral Solution

Approval Number: 国药准字H20253289
Registration: Jan 24, 2025
南京泽恒医药技术开发有限公司

Olmesartan Medoxomil and Amlodipine Besylate Tablets

Approval Number: 国药准字H20253231
Registration: Jan 24, 2025
江苏联环药业股份有限公司

Ixazomib Citrate Capsules

Approval Number: 国药准字H20253308
Registration: Jan 24, 2025
山东齐鲁制药有限公司

Sitafloxacin Granules

Approval Number: 国药准字H20253317
Registration: Jan 24, 2025
济川药业集团有限公司

Potassium Chloride Oral Solution

Approval Number: 国药准字H20253291
Registration: Jan 24, 2025
哈尔滨誉衡制药有限公司

Tacrolimus Sustained-release Capsules

Approval Number: 国药准字H20253241
Registration: Jan 24, 2025
山东鲁抗辰欣药业有限公司

Dapagliflozin Tablets

Approval Number: 国药准字H20253304
Registration: Jan 24, 2025
河北智恒医药科技股份有限公司

Macrogol Sodium Potassium Powder

Approval Number: 国药准字H20253326
Registration: Jan 24, 2025
圣嘉（滨海）生物医药科技有限公司

Dapagliflozin Tablets

Approval Number: 国药准字H20253316
Registration: Jan 24, 2025
江苏德源药业股份有限公司

Avatrombopag Maleate tablet

Approval Number: 国药准字H20253325
Registration: Jan 24, 2025
山东凤凰制药股份有限公司

Aripiprazole Orally Disintegrating Tablets

Approval Number: 国药准字H20253237
Registration: Jan 24, 2025
北京星昊医药股份有限公司

Tulobuterol Patch

Approval Number: 国药准字H20253279
Registration: Jan 24, 2025
北京泰德制药股份有限公司

Exemestane Tablets

Approval Number: 国药准字H20253283
Registration: Jan 24, 2025
重庆圣华曦药业股份有限公司

Fulvestrant Injection

Approval Number: 国药准字H20253243
Registration: Jan 24, 2025
南京健友生化制药股份有限公司

Multiple Electrolytes Injection(Ⅱ)

Approval Number: 国药准字H20253260
Registration: Jan 24, 2025
杭州民生药业股份有限公司

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.